Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Change in Inventory (2020 - 2025)

Maravai Lifesciences Holdings (MRVI) has 6 years of Change in Inventory data on record, last reported at -$3.1 million in Q4 2025.

  • For Q4 2025, Change in Inventory fell 584.07% year-over-year to -$3.1 million; the TTM value through Dec 2025 reached -$8.0 million, down 2021.75%, while the annual FY2025 figure was -$8.0 million, 2021.75% down from the prior year.
  • Change in Inventory reached -$3.1 million in Q4 2025 per MRVI's latest filing, down from -$1.3 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $13.8 million in Q1 2021 and bottomed at -$19.3 million in Q4 2022.
  • Average Change in Inventory over 5 years is $154500.0, with a median of -$450500.0 recorded in 2024.
  • Peak YoY movement for Change in Inventory: soared 381.68% in 2023, then crashed 584.07% in 2025.
  • A 5-year view of Change in Inventory shows it stood at -$4.7 million in 2021, then plummeted by 311.03% to -$19.3 million in 2022, then soared by 111.33% to $2.2 million in 2023, then tumbled by 120.7% to -$452000.0 in 2024, then plummeted by 584.07% to -$3.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Inventory were -$3.1 million in Q4 2025, -$1.3 million in Q3 2025, and -$3.1 million in Q2 2025.